We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 14, 2018

Validating Digital Health: A Process for Success

Commentary
Maeve Lyons
&

Show me the money

Despite billions and billions of dollars of investment, Digital Health is still searching for great examples of how it can improve the patient experience and deliver improved healthcare outcomes.

Unfortunately, there is a lot of bad news:

It is easy for even the most optimistic observer to conclude that it is all snake oil.

You see it take 17 years in healthcare from when we agree that something is the right thing to do….to widespread adoption.

There are lots of antibodies (i.e. people) who can kill your business. As an innovator you need to get a whole army of different stakeholders on side to stand a chance of survival. Depending on your solution you may need to convince some or all of the following

Show me the evidence

How do you distinguish the signal from the noise in this exponentially expanding environment?

The current gold standard for clinical evidence is peer review which is usually published in a reputable journal.

Digital Health is however a hybrid sector at the intersection of medicine, technology, health economics, policy and the social sciences - so naturally we will need evidence and endorsement from from multiple stakeholders and expert groups.

Anyone who has been through this peer review process will recall the long hours spent and the vast amounts of energy spent jumping through tedious hoops. Is all this effort worth it, and how does this fit with the rapidly expanding digital health solutions making their way onto the market? What others options are there to validate the efficacy of a tech solution that claims to be able to improve medication adherence with the help of telemedicine or improve cancer patients chances of survival and improved quality of life through a digital therapeutic?

Does digital health validation belong in the world of peer reviewed journals?

There is mounting speculation around the need for the peer review process to be reformed. While the system is not flawless it a proven and trusted method and a hallmark of quality.

However for digital health companies the current model is a challenge. Some of the barriers for these solutions looking to gain credibility, are also barriers to the experts looking to contribute to the validation of the most promising digital health solutions, include the following:

Pace: Digital health is championed for introducing agility into an traditionally static healthcare environment, yet the peer review process is notoriously known for lag times introducing a mismatch when it comes to the the digital health solution arena

Feedback Loops: The peer review process is a closed feedback loop that all too often will direct authors in the right direction to improve their paper but beyond that the feedback will likely not direct the authors and researchers in the right direction in terms of long term improvements to their process and work. Beyond this openness and community building around these experts and innovators is key to moving forward towards real impact rather than a transactional process

The Good News

The peer review process must remain a credible source of information when it comes to the communication of clinical efficacy of digital health solutions. But while we push for this existing process to align with the pace and essential long term and open feedback loops, HealthXL are giving the digital health community confidence in the most promising solutions through our HealthXL Verified program.

We have been working with our global healthcare community on this very topic as we try to assess the landscape. So, where do we go from here?

How this works

The HealthXL community is made up of the leading minds in digital health globally who have unique experience and insights. We are now putting them to work to highlight those companies who are really driving the sector forward.In short to help them stand out from the crowd and evolve with the help of the community (see below)

HealthXL collects publication data from trusted medical journals as well case studies put forward by companies to support their claim. We work with innovators to identify suitable advisors who can provide confidential feedback on any non peer reviewed piece of evidence.

Check out the two minute video explaining the process

 

Looking to Engage with the Next Wave of Evidence Based Digital Health?

To date were have seen that 70% of the company views on our platform are HealthXL Verified companies including the top 10 viewed companies all being HealthXL Verified.“As a busy clinician, I don’t really have time to sift through all the various websites to look for applications that are useful. HealthXL have got the right evidence that makes it easy to find the best solutions for our health service.” - Dr. Kwang Lim, Clinical Director of Medicine and Aged Care, Royal Melbourne Hospital
We’re calling on entrepreneurs, clinical adopters and active investors who are interested to get involved in defining and assessing the golden standard for digital health.

If interested, please contact HealthXL’s Chief Medical Officer Dr Chandana Fitzgerald at chandana@healthxl.org to continue the conversation and learn more

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to get your DTx product reimbursed in the US?

4th November @ 11:45AM EDT

Are you a DTx company seeking reimbursement in the US? Then this masterclass is for you. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through how to get your DTx product reimbursed in the US.

Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DiGa - Entering the digital health space in Germany

10th November @ 10:45AM EDT

Join us in this interactive masterclass led by Flying Health, as they discuss what you need to know to navigate the DiGa framework. Apply now to learn valuable insights from thought leaders in this space.

Featuring
Laura Nelde
Laura Nelde
Startup Relationship Manager at Flying Health
Len-Philipp Ortlepp
Len-Philipp Ortlepp
Junior Startup Relationship Manager, Flying Health
Featuring
Laura Nelde
Laura Nelde
Startup Relationship Manager at Flying Health
Len-Philipp Ortlepp
Len-Philipp Ortlepp
Junior Startup Relationship Manager, Flying Health

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Commercialisation models for Virtual Care in Respiratory Diseases

3rd November @ 11:45AM EDT

Join our Digital Health Meeting as we discuss commercialisation models for Virtual Care in Respiratory Diseases. Apply now to hear from fellow peers in this space and share your own thoughts and experiences on this topic.

Featuring
Peter Small
Peter Small
Chief Medical Officer, Hyfe
Caleb Bank
Caleb Bank
Product Marketing at NuvoAir
Featuring
Peter Small
Peter Small
Chief Medical Officer, Hyfe
Caleb Bank
Caleb Bank
Product Marketing at NuvoAir
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to get your DTx product reimbursed in the US?

4th November @ 11:45AM EDT

Are you a DTx company seeking reimbursement in the US? Then this masterclass is for you. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through how to get your DTx product reimbursed in the US.

Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.